Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from Dr Reddy’s Laboratories ( ...

Dr Reddy’s Laboratories beat street estimates in the September quarter, with a revenue of ₹8,805 crore and profit after tax of ₹1,437 crore, buoyed by growth in branded markets and its nicotine ...

Hyderabad-based pharma major Dr Reddy Laboratories on Friday reported a consolidated net profit of ₹1,437.2 crore in the second quarter of the financial year 2025-26 (Q2FY26), marking a 14 per cent ...

Dr Reddy's Laboratories Ltd.'s profit in the second quarter of this financial year rose 7.3% to Rs 1,347 crore in quarter ended September. This is in comparison to profit of Rs 1,256 crore in the same ...

Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY) reported its consolidated financial results for the second quarter of FY26, showing healthy growth in revenue and net profit despite a slight ...

Dr Reddy's Laboratories, Aditya Birla Sun Life AMC, ITC Hotels, SBI Life Insurance Company, and NACL Industries are among the key firms scheduled to release their Q2FY26 (July–September) financial ...

Dr. Reddy's Laboratories Ltd., Coforge Ltd., SBI Life Insurance Company Ltd. and SBI Cards and Payments Services Ltd. are among the top names that will announce their quarterly results on Friday. Dr.

Dr. Reddy's Laboratories Ltd. 500124 shares inched up 0.32% to 1,284.00 Indian rupees Friday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index 1 ...

Leading Indian pharmaceutical major Dr Reddy's Laboratories, is expected to post moderate year-on-year growth in the September 2025 quarter (Q2 FY26). The company's performance is likely to be driven ...

Q2 Results Live Updates: SBI Life Insurance Q2 net falls 6.59% at Rs 494.59 crore as GST cuts impact profitability Private sector insurer SBI Life Insurance on Friday reported a 6.59 per cent ...

HYDERABAD, India (AP) — HYDERABAD, India (AP) — Dr. Reddy's Laboratories Ltd. (RDY) on Friday reported earnings of $162 million in its fiscal second quarter. On a per-share basis, the Hyderabad, India ...